The Netherlands Authority for Consumers and Markets (ACM) announced that the prices of prescription drugs is one of the four key priorities on ACM’s agenda in 2018-2019. On 12 April 2018, Diederik Schrijvershof speaks about ACM’s and the European Commission’s oversight efforts regarding (expensive) prescription drugs.
Competition | Regulation | Litigation
Maverick Advocaten speaks about ACM’s and the European Commission’s oversight efforts regarding expensive prescription drugs
14-02-2018
